Unlocking the Therapeutic Potential of Ganoderma lucidum : From Bioactive Compounds to Clinical Translation
Phytotherapy Research · 2026-07 · 40 (7) · 4532-4555
DOI: 10.1002/ptr.70356 ↗At a glance
Übersichtsarbeit in Phytotherapy Research, published online on 2026-05-11. Written by Gadallah Mohamed and 7 co-authors. Institution: College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China. Major MEDLINE topics: Reishi, Phytochemicals. Cited 1 times so far (Crossref); 119 references. Funded by: Zhejiang Province "Spearhead" and "Leading Wild Goose" Research and Development Project of Bilateral Industrial Joint Research and Development.
Abstract (original language)
Ganoderma lucidum , a revered medicinal mushroom with a rich history in traditional East Asian medicine, has garnered significant scientific attention for its diverse pharmacological properties. This comprehensive review synthesises recent advancements in understanding the phytochemistry, biological activities and therapeutic applications of G. lucidum . We delve into the intricate composition of its bioactive compounds, including polysaccharides, triterpenoids, sterols and phenolic compounds, elucidating their mechanisms of action in immunomodulation, anti‐inflammatory responses, antioxidant defence, hepatoprotection and anticancer potential. Furthermore, this review examines emerging applications in nanotechnology, where G. lucidum extracts are utilised for the green synthesis of nanoparticles and as components in advanced drug delivery systems, antimicrobial nanomaterials and biosensors. We also discuss its expanding role in nutraceuticals, functional foods and cosmeceuticals, highlighting its anti‐aging, skin‐brightening and calming properties. Finally, the safety profile and toxicological evaluations of G. lucidum are critically assessed, alongside its growing economic significance. This review underscores the immense therapeutic potential of G. lucidum as a natural resource for modern medicine and biotechnology, while also identifying key challenges and future directions for research to facilitate its broader clinical and industrial translation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
- Zhejiang International Joint Laboratory of Traditional Medicine and Big Health Products Development, Hangzhou, China.
- Biochemistry Department, Faculty of Agriculture, Al Azhar University, Cairo, Egypt.
- School of Social Sciences, Lingnan University, Hong Kong, China.
- Platform for Unique Models Application, Department of Pharmaceutical Microbiology and Parasitology, Wroclaw Medical University, Wrocław, Poland.
- Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
ORCID profiles: Lifan Yu, Gautam Sethi
Funding
- Zhejiang Province "Spearhead" and "Leading Wild Goose" Research and Development Project of Bilateral Industrial Joint Research and Development
Cite
APA
Mohamed, G., Sun, Z., Yu, L., Junka, A., Bei, R., Sethi, G., Yu, M., & Sun, Y. (2026). Unlocking the Therapeutic Potential of Ganoderma lucidum : From Bioactive Compounds to Clinical Translation. Phytotherapy Research, 40(7), 4532-4555. https://doi.org/10.1002/ptr.70356
Vancouver
Mohamed G, Sun Z, Yu L, Junka A, Bei R, Sethi G, et al. Unlocking the Therapeutic Potential of Ganoderma lucidum : From Bioactive Compounds to Clinical Translation. Phytotherapy Research. 2026;40(7):4532-4555. doi:10.1002/ptr.70356
BibTeX
@article{Mohamed2026,
author = {Mohamed, Gadallah and Sun, Zhixin and Yu, Lifan and Junka, Adam and Bei, Ruixin and Sethi, Gautam and Yu, Mingzhe and Sun, Yanfang},
title = {Unlocking the Therapeutic Potential of Ganoderma lucidum : From Bioactive Compounds to Clinical Translation},
journal = {Phytotherapy Research},
year = {2026},
volume = {40},
number = {7},
pages = {4532--4555},
doi = {10.1002/ptr.70356}
}
EUVIMED